Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Neoplasms × Erythropoietin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Anemia 4 Uterine Cervical Neoplasms 2 Myelodysplastic Syndromes 2 Leukemia 2 Rectal Neoplasms 1 Radiation Injuries 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma 1 Lichen Planus, Oral 1 Leukemia, Myelomonocytic, Chronic 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Erectile Dysfunction 1 Drug-Related Side Effects and Adverse Reactions 1

Interventions

Cisplatin 223 Radiotherapy 158 Cetuximab 123 pembrolizumab 103 Fluorouracil 84 Docetaxel 82 Paclitaxel 72 Carboplatin 69 Radiotherapy, Intensity-Modulated 62 Nivolumab 34 Radiation 28 Drug Therapy 26 Gemcitabine 23 Erlotinib Hydrochloride 20 Gefitinib 19 Standard of Care 18 durvalumab 17 Surveys and Questionnaires 17 Surgical Procedures, Operative 17 Pemetrexed 17 Magnetic Resonance Spectroscopy 17 Cyclophosphamide 17 atezolizumab 15 Capecitabine 15 Everolimus 14 Bevacizumab 14 Amifostine 14 Radiosurgery 13 Low-Level Light Therapy 13 Immunohistochemistry 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01467115 2017-05-09

DREXNECK

Drexel University

Phase 2 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡